MedTrace Logo

Fetuin-A as a Marker in Obesity and Type 2 Diabetes Mellitus

NCT04218305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-01-06

No results posted yet for this study

Summary

The aim of this study is to assess the significance of serum fetuin-A as a marker of obesity and type 2 diabetes mellitus. We used multiple statistical approaches to determine that the fetuin-A level is correlated to body mass index (BMI) as well as random blood sugar in type 2 diabetic patients. Also, we found that there is a Positive correlation between the serum fetuin-A levels and the level of glycosylated hemoglobin (HbA1c) in diabetic patients.

Conditions

  • Diabete Type 2

Interventions

DIAGNOSTIC_TEST

Serum Level Of Fetuin A

Sponsors & Collaborators

  • Minia University

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-02-01
Completion
2016-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04218305 on ClinicalTrials.gov